Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplasms
|
1644 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.100 | 1.000 | 11 | 2013 | 2019 | ||||||
Glioblastoma
|
281 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.080 | 1.000 | 8 | 2013 | 2018 | ||||||
Diffuse Intrinsic Pontine Glioma
|
9 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.060 | 1.000 | 6 | 2012 | 2020 | ||||||
Glioblastoma Multiforme
|
186 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.050 | 1.000 | 5 | 2013 | 2017 | ||||||
Glioma
|
353 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.050 | 0.800 | 5 | 2016 | 2020 | ||||||
Astrocytoma
|
59 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.720 | 1.000 | 3 | 2013 | 2016 | ||||||
GLIOMA SUSCEPTIBILITY 1
|
14 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.700 | 1.000 | 3 | 2012 | 2013 | ||||||
Adult Glioblastoma
|
98 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||||
Childhood Glioblastoma
|
98 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.030 | 1.000 | 3 | 2016 | 2017 | ||||||
Brain Neoplasms
|
204 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.020 | 0.500 | 2 | 2018 | 2019 | ||||||
Cerebellar Neoplasms
|
5 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.020 | 1.000 | 2 | 2017 | 2018 | ||||||
Childhood Ganglioglioma
|
4 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.020 | 1.000 | 2 | 2018 | 2018 | ||||||
Ganglioglioma
|
7 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.020 | 1.000 | 2 | 2018 | 2018 | ||||||
Brain Stem Glioma
|
45 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Gliosarcoma
|
5 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Anaplastic astrocytoma
|
12 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Brain Stem Glioblastoma
|
1 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinogenesis
|
355 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Central Nervous System Neoplasms
|
72 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Childhood Gliosarcoma
|
5 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
gliosarcoma
|
5 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
High Grade Astrocytic Tumor
|
2 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
High grade glioma
|
15 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Low grade glioma
|
10 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Glioma
|
22 | 0.683 | 0.080 | 1 | 226064434 | missense variant | A/T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |